RNS Number : 3950M
Intuitive Investments Group plc
11 January 2023
 

11 January 2023

 

Intuitive Investments Group plc

 

Investment in Yourgene Health plc

 

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, has invested £150,407 to acquire 50 million ordinary shares of Yourgene Health plc (AIM: YGEN) ("Yourgene") at a price of 0.3 pence per share. IIG holds 51,584,920 ordinary shares of Yourgene in total.

 

Julian Baines, Chairman of IIG and Robert Naylor, CEO of IIG, have holdings of 5,000,000 ordinary shares and 33,497,789 ordinary shares in Yourgene respectively

For further information, please contact:

Intuitive Investments Group plc

www.iigplc.com

Julian Baines, Chairman

Robert Naylor, CEO

Via Walbrook PR

 


SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0) 20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

 


Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope


 


Walbrook PR Limited - Media & Investor Relations

+44 (0)20 7933 8780 or intuitive@walbrookpr.com

Paul McManus / Sam Allen

+44 (0) 7980 541 893 / +44 (0) 7502 558 258

 

About Intuitive Investments Group plc

Intuitive Investments Group plc is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFLSUFEDSELF